By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing new generation therapies for unmet medical needs72.1K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States72.1K100.00%